Dose-response Study of OPC-12759 Ophthalmic Suspension

Clinical trial NCT00234078 · COMPLETED

Trial details

NCT number: NCT00234078
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2005-01-01
Primary completion: 2006-04-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.